Detalhe da pesquisa
1.
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
Lipids Health Dis
; 15(1): 116, 2016 Jul 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-27405296
2.
Blood pressure-lowering effects of extended-release niacin alone and extended-release niacin/laropiprant combination: a post hoc analysis of a 24-week, placebo-controlled trial in dyslipidemic patients.
Clin Ther
; 31(1): 115-22, 2009 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-19243712
3.
Effects of sources of variability on sample sizes required for RCTs, applied to trials of lipid-altering therapies on carotid artery intima-media thickness.
Clin Trials
; 6(4): 305-19, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19667027
4.
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia.
Am J Cardiol
; 101(5): 625-30, 2008 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-18308010
5.
Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia.
Am Heart J
; 153(2): 335.e1-8, 2007 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-17239698
6.
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
Am J Cardiol
; 119(3): 388-396, 2017 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27956003
7.
A Multiregional, Randomized Evaluation of the Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients With Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
Am J Cardiol
; 120(4): 569-576, 2017 Aug 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28624096
8.
Reduction of cardiovascular events by simvastatin in nondiabetic coronary heart disease patients with and without the metabolic syndrome: subgroup analyses of the Scandinavian Simvastatin Survival Study (4S).
Diabetes Care
; 27(7): 1735-40, 2004 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-15220255
9.
LDL-C goal attainment with ezetimibe plus simvastatin coadministration vs atorvastatin or simvastatin monotherapy in patients at high risk of CHD.
MedGenMed
; 7(3): 3, 2005 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-16369229
10.
Muscle Complaints or Events in Patients Randomized to Simvastatin or Ezetimibe/Simvastatin.
J Am Coll Cardiol
; 75(7): 835-837, 2020 02 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32081289
11.
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
Vasc Health Risk Manag
; 11: 165-72, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25750540
12.
Effects of simvastatin on C-reactive protein in mixed hyperlipidemic and hypertriglyceridemic patients.
Am J Cardiol
; 90(9): 942-6, 2002 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-12398959
13.
Efficacy and safety of ezetimibe coadministered with simvastatin in patients with primary hypercholesterolemia: a randomized, double-blind, placebo-controlled trial.
Mayo Clin Proc
; 79(5): 620-9, 2004 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15132403
14.
Comparative effects of simvastatin and atorvastatin in hypercholesterolemic patients with characteristics of metabolic syndrome.
Clin Ther
; 25(6): 1670-86, 2003 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-12860491
15.
Effects of simvastatin on the lipid profile and attainment of low-density lipoprotein cholesterol goals when added to thiazolidinedione therapy in patients with type 2 diabetes mellitus: A multicenter, randomized, double-blind, placebo-controlled trial.
Clin Ther
; 26(3): 379-89, 2004 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-15110130
16.
Effects of simvastatin, an HMG-CoA reductase inhibitor, in patients with hypertriglyceridemia.
Clin Cardiol
; 26(1): 18-24, 2003 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-12539808
17.
Effects of extended-release niacin/laropiprant, simvastatin, and the combination on correlations between apolipoprotein B, LDL cholesterol, and non-HDL cholesterol in patients with dyslipidemia.
Vasc Health Risk Manag
; 10: 279-90, 2014.
Artigo
em Inglês
| MEDLINE | ID: mdl-24855368
18.
Effectiveness and safety of laropiprant on niacin-induced flushing.
Am J Cardiol
; 110(6): 817-22, 2012 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22683042
19.
Niacin lipid efficacy is independent of both the niacin receptor GPR109A and free fatty acid suppression.
Sci Transl Med
; 4(148): 148ra115, 2012 Aug 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-22914621
20.
High-dose statins in acute coronary syndromes.
JAMA
; 293(1): 37; author reply 38-9, 2005 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-15632330